Ober Laboratory · University of Chicago · Department of Human Genetics
Research
Our studies leverage complementary research designs – birth cohorts, cross sectional and longitudinal studies, founder populations, and experimental approaches through the UChicago Asthma Genomics Center – each offering unique advantages for understanding the genetic and epigenetic underpinnings of asthma and allergic disease.
Birth Cohorts
Early Intervention: Elucidating early life molecular trajectories of asthma risk in airway cells.
Collaborators: J. Gern, PI (UWisconsin), L. Bacharier (Vanderbilt), M. Kattan (Columbia U), G. O'Connor (Boston U), K. Rivera-Spoljaric (Wash U), R. Wood (JHU), NIAID (UM1 AI160040)
URECA — Urban Environment and Childhood Asthma
Collaborators: A. Singh (PI), T. Hartert (Vanderbilt U, Nashville), K. Rivera-Spoljaric (Wash U), E. Zoratti (Henry Ford Health, Detroit), C. McKennan (U Pittsburgh), S. Lynch (UCSF), M. Altman (Benaroya Research Institute, Seattle) (NIAID R01 AI202514)
CANOE — Early life epithelial development and asthma
Papers coming shortly.
Collaborators: Y. Li (UNC), C. Keet (UNC), D. Jackson (UWisconsin), P. Ryan (U Cincinnati), SUNBEAM Investigators, NIAID (U01 AI190013)
Multi-omic and environmental predictors of allergic disease development and progression in early life
Newly funded in 2026.
Collaborators: J. Gern, PI (UWisconsin) and CADRE investigators, NIAID (U24 AI179612)
CADRE — Children's Allergy & Asthma Data Repository
Cross Sectional and Longitudinal Studies
Personalizing Medicine: Identifying genetic and epigenetic signatures of asthma endotypes and predictors of response to asthma biologics in children.
Collaborators: D. Jackson, PI (UWisconsin), J. Gern (UWisconsin), C. McKennan (U Pittsburgh), S. Lynch (UCSF), M. Altman (Benaroya Research Institute, Seattle), and the CAUSE investigators, NIAID (UM1 AI160040)
CAUSE — Childhood Asthma in Urban Settings
Collaborators: W. Phipatanakul, PI (Boston Children's Hospital), C. McKennan (U Pittsburgh), PARK investigators, NIAID (U01 AI179563)
Controlling and preventing asthma progression and severity in kids with omalizumab
Funded in 2025.
Founder Populations
Mechanisms of Protection: Studying molecular mechanisms of asthma protection in Amish children.
Collaborators:D. Vercelli (U Arizona), N. Schoettler (UChicago), M. Holbreich (NIAID R56 AI201174)
Amish and Hutterite Studies
UChicago Asthma Genomics Center
Leveraging molecular and cellular phenotypes to identify and characterize novel asthma genes and pathways
Collaborators: M. Nóbrega, X. He, N. Schoettler, S. Nyenhuis, NIAID (U19 AI162310)
Representative Publications